The recorded playback and session evaluation is now available for
Focus on Research 2009 Webinar -Proteomics
Speaker: Henry Rodriguez, Ph.D., M.B.A.
Recorded Thursday, May 14, 2009 Session Number: 717 210 723
Link to recorded playback:
https://lcs.webex.com/lcs/playback.php?FileName=http://media.linkconferencecall.com/resources/stream/RAN_05142009.wrf
(This link works best when accessed with Internet Explorer)
Please complete the session evaluation at:
https://www.surveymonkey.com/s.aspx?sm=0LkisbU9N7gqufTMjtCuAg_3d_3d
(to be completed if attended "live" or via playback)
Session Preparatory Assignment:
Read the primer from NCI Clinical Proteomics Technologies for Cancer (CPTC) by clicking here Proteomics Primer (pdf also available on their website to download)
Speaker:
Henry Rodriguez, Ph.D., M.B.A.
Director, Clinical Proteomic Technologies for Cancer
Office of the Director
National Cancer Institute
|
|
|
Henry Rodriguez
|
Dr. Rodriguez serves as the Director of the Clinical Proteomic Technologies for Cancer programs within the NCI's Office of Technology and Industrial Relations, in the Office of the Director. In this role, he oversees and is responsible for the vision, direction, and implementation of highly complex scientific proteomic technology programs. These initiatives consist of the Clinical Proteomic Technologies for Cancer initiative (CPTC) and the Mouse Proteomic Technologies Initiative (MPTI).
Dr. Rodriguez is an internationally recognized expert in advanced molecular-based cancer technologies, specifically proteomics, genomics, cellomics, and bioinformatics. Immediately before coming the to NCI in 2006, Dr. Rodriguez was at the National Institute of Standards and Technology (NIST), where he held several roles (1998-2006). At NIST, Dr. Rodriguez developed and was the Leader of the Cell & Tissue Measurements Group, where he successfully established four advanced technology research programs in the areas of quantitative cell biology/cellomics, proteomics, gene expression, and bioinformatics. Initiatives in proteomic metrology included protein capture chemistry, mass spectrometry, protein sequencing, peptide synthesis, and database development.
Dr. Rodriguez received a B.S. and M.S. in Biology from Florida International University, a Ph.D. in Cell and Molecular Biology from Boston University, and an M.B.A. from Johns Hopkins University School of Business Management.
For more information about Dr. Rodriguez and the Clinical Proteomic Technologies for Cancer go to http://proteomics.cancer.gov/about/leadership.asp.